Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genezen is an active CDMO specializing in the development and GMP manufacturing of viral vectors for gene and cell therapy applications. The company provides process development, analytical testing services, and cGMP-compliant production capabilities to support early-phase through commercial programs. It has established strategic collaborations with leading research institutions such as Seattle Children’s Research Institute to advance gene therapy programs like those targeting X-linked agammaglobulinemia (XLA). No direct clinical results are reported since it does not develop its own therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Genezen.